KR102195156B1 - Antimicrobial Adhesive Composition and Method For Preparing Same - Google Patents
Antimicrobial Adhesive Composition and Method For Preparing Same Download PDFInfo
- Publication number
- KR102195156B1 KR102195156B1 KR1020180143688A KR20180143688A KR102195156B1 KR 102195156 B1 KR102195156 B1 KR 102195156B1 KR 1020180143688 A KR1020180143688 A KR 1020180143688A KR 20180143688 A KR20180143688 A KR 20180143688A KR 102195156 B1 KR102195156 B1 KR 102195156B1
- Authority
- KR
- South Korea
- Prior art keywords
- lys
- tyr
- gly
- antimicrobial
- adhesive protein
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/20—Diluents or solvents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/61—Additives non-macromolecular inorganic
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
본 발명은 항균 펩타이드를 포함하는 접착 단백질 및 도파민을 포함하는 항균 기능성 코팅 조성물 및 이의 제조 방법에 관한 것으로, 본 발명에 따른 항균 코팅 조성물은 종래의 홍합 유래 접착제의 문제점인 장시간 접착 혹은 코팅이 필요한 단점을 개선하여 단시간에 강력한 접착력을 갖는 동시에 인체 유해한 그람 양성균, 그람 음성균, 세균, 진균 등 다양한 미생물이나 바이러스에 항균 효과를 나타낼 수 있는 코팅 조성물을 제공한다.The present invention relates to an antibacterial functional coating composition containing an adhesive protein containing an antimicrobial peptide and dopamine, and a method for manufacturing the same, and the antimicrobial coating composition according to the present invention requires a long time adhesion or coating which is a problem of a conventional mussel-derived adhesive. It provides a coating composition capable of exhibiting an antibacterial effect on various microorganisms or viruses such as gram-positive bacteria, gram-negative bacteria, bacteria, and fungi that are harmful to the human body while having strong adhesion in a short time.
Description
본 발명은 항균 접착 단백질을 이용하여 고분자, 유리, 금속, 원단 등 다양한 기재 상에 항균 기능을 부여할 수 있는 코팅 조성물에 관한 것으로, 보다 상세하게는, 항균 펩타이드를 포함하는 홍합 접착 단백질을 이용하여 섬유나 유리 등의 기재 상에 코팅하여 항균 기능을 부여할 수 있는 코팅 조성물 및 이의 제조 방법에 관한 것이다.The present invention relates to a coating composition capable of imparting an antimicrobial function on various substrates such as polymers, glass, metal, fabric, etc. by using an antibacterial adhesive protein. It relates to a coating composition capable of imparting an antibacterial function by coating on a substrate such as fiber or glass, and a method of manufacturing the same.
홍합이나 따개비가 분비하는 접착제는 내수성 접착제이면서 단백질로 구성된 생체 접착제로서, 인체에 무해하며 면역반응을 일으키지 않는 것으로 알려졌다. 또한, 단백질로 구성된 접착제이기 때문에 미생물이나 효소 작용에 의해 생분해되는 환경 친화형 접착제이기도 하다.The adhesive secreted by mussels and barnacles is a water-resistant adhesive and a bio-adhesive made of protein, and is known to be harmless to the human body and not cause an immune response. In addition, since it is an adhesive made of protein, it is also an environmentally friendly adhesive that is biodegraded by the action of microorganisms or enzymes.
홍합의 족사에서 분비되는 홍합 접착 단백질은 아미노산인 티로신의 수산화 공정으로 만들어진 3,4-디하이드록시페닐-L-알라닌(3,4-dihydroxyphenyl-L-alanine; L-DOPA)을 평균 20% 이상 함유하며, DOPA는 접착 기능에 핵심적인 역할을 하는 것으로 알려졌다. DOPA 잔기는 산화 과정을 거쳐 전환된 도파 퀴논(DOPA-quinone)을 통하여 접착 단백질들간의 가교반응을 통하여 강력한 접착력을 발휘한다.The mussel adhesive protein secreted from the mussel's foot is an average of 20% or more of 3,4-dihydroxyphenyl-L-alanine (L-DOPA), which is made by the hydroxylation process of the amino acid tyrosine. And DOPA is known to play a key role in the adhesion function. DOPA residues exhibit strong adhesion through crosslinking reactions between adhesion proteins through dopa-quinone converted through an oxidation process.
그러나, 홍합 접착 단백질은 접착력을 발휘하는데 최소 12시간 이상 소요되어 산업적 응용이 제한되고 있다.However, the mussel adhesive protein takes at least 12 hours or more to exhibit adhesion, and thus industrial applications are limited.
최근에는, 홍합 접착 단백질의 문제점을 극복하기 위한 방법으로 홍합 접착 단백질을 모방한 폴리도파민이나 폴리에틸렌 글리콜에 도파민이 도입된 합성 고분자를 이용한 접착/코팅 기술이 활발히 연구개발되고 있다.In recent years, as a method for overcoming the problem of mussel adhesion protein, an adhesion/coating technology using polydopamine imitating mussel adhesion protein or synthetic polymer in which dopamine is introduced into polyethylene glycol has been actively researched and developed.
접착에 장시간 소요되는 홍합 접착 단백질과 달리 폴리도파민은 적절한 용매와 산화제를 사용시 수분 이내에 코팅이 가능하며, 화학 합성 공정을 통해 대량 생산이 가능한 장점이 있어 산업적 응용 연구개발이 활발히 진행되고 있다.Unlike mussel adhesive proteins, which take a long time for adhesion, polydopamine can be coated within minutes when using an appropriate solvent and oxidizing agent, and has the advantage of mass production through a chemical synthesis process, so industrial application research and development are actively progressing.
예를 들어, 공개특허 공고 제10-2013-0031163호에서는 폴리도파민에 산화제를 첨가하여 알칼리성 용매를 사용하여 코팅 시간을 수분 이내로 단축시키는 방법을 제시하고 있다.For example, Korean Patent Publication No. 10-2013-0031163 proposes a method of shortening the coating time within minutes by using an alkaline solvent by adding an oxidizing agent to polydopamine.
그러나, 폴리도파민은 분자 구조상 벤젠링을 포함하여 경도는 높으나 외부 충격에 쉽게 부서지는 내충격성이 취약한 단점이 있으며, 알칼리성 용매에서 도파민과 산화제로 구성된 코팅 조성물은 중합 반응이 매우 빨라 반응 제어가 쉽지 않아 불균일한 표면 코팅의 문제가 있었다. 이러한 문제점들은 폴리도파민의 산업적 용도를 제한할 수 있다However, polydopamine has a high hardness including benzene ring due to its molecular structure, but has a weak impact resistance, which is easily broken by external impact.The coating composition composed of dopamine and an oxidizing agent in an alkaline solvent has a very rapid polymerization reaction, making it difficult to control the reaction. There was a problem of uneven surface coating. These problems may limit the industrial use of polydopamine.
본 발명의 목적은 상술한 바와 같은 문제점을 해결하고자 하는 것으로서, 접착력이 빠르게 작용하면서도 다양한 표면에 균일하게 코팅될 수 있으며, 폴리도파민이 가지는 취약한 내충격성 등 기계적 물성을 개선하여 산업적 적용이 용이하며 항균 지속력이 우수한 항균 코팅 조성물을 제공하는 것이다.An object of the present invention is to solve the above-described problems, it can be uniformly coated on various surfaces while the adhesive force acts quickly, and it is easy to apply industrially by improving mechanical properties such as weak impact resistance of polydopamine, and antibacterial It is to provide an antibacterial coating composition having excellent lasting power.
본 발명의 또 다른 목적은 위와 같은 항균 코팅 조성물을 제조하는 방법을 제공하는 것이다.Another object of the present invention is to provide a method of preparing an antibacterial coating composition as described above.
상기 과제를 해결하기 위해서, 본 발명의 일 구현 양태는, 항균성 펩타이드가 결합된 접착 단백질; 및 도파민을 포함하는 항균 코팅 조성물을 제공한다.In order to solve the above problems, one embodiment of the present invention, an antimicrobial peptide bonded adhesive protein; And it provides an antibacterial coating composition comprising dopamine.
본 발명에서, 상기 접착 단백질은 홍합(Mussel) 유래 접착 단백질, 따개비(Barnacle) 유래 접착 단백질 및 그의 조합으로 구성된 군에서 선택될 수 있다.In the present invention, the adhesive protein may be selected from the group consisting of an adhesive protein derived from mussels (Mussel), an adhesive protein derived from Barnacle, and combinations thereof.
본 발명에서, 상기 접착 단백질은 티로신 잔기가 도파(DOPA) 또는 도파 퀴논으로 수정된 것을 특징으로 할 수 있다.In the present invention, the adhesion protein may be characterized in that the tyrosine residue is modified with dopa (DOPA) or dopa quinone.
본 발명에서, 상기 접착 단백질 및 도파민을 10:1 내지 1:1의 중량비로 포함하는 항균 코팅 조성물을 제공한다.In the present invention, it provides an antibacterial coating composition comprising the adhesive protein and dopamine in a weight ratio of 10:1 to 1:1.
본 발명의 항균 코팅 조성물은 pH 7.0 초과 9.0 이하의 약알칼리성 용매를 포함할 수 있다.The antimicrobial coating composition of the present invention may include a weakly alkaline solvent having a pH of greater than 7.0 and less than or equal to 9.0.
상기 용매는 초산나트륨(sodium acetate), 탄산수소나트륨(sodium bicarbonate), 아인산염(phosphate) 및 이들의 조합으로부터 선택될 수 있다.The solvent may be selected from sodium acetate, sodium bicarbonate, phosphate, and combinations thereof.
본 발명의 항균 코팅 조성물은 산화제로서 철(Fe3+), 크롬(Cr6+), 망간(Mn7+) 및 요오드(I7+)로 이루어진 군으로부터 선택된 하나 이상의 금속, 과산화수소 또는 과산화이중황산나트륨(Na2S2O8)을 포함할 수 있다.The antimicrobial coating composition of the present invention is one or more metals selected from the group consisting of iron (Fe 3+ ), chromium (Cr 6+ ), manganese (Mn 7+ ) and iodine (I 7+ ) as an oxidizing agent, hydrogen peroxide, or sodium peroxide bisulfate. (Na 2 S 2 O 8 ) may be included.
본 발명의 다른 구현 양태는, 항균성 펩타이드가 결합된 접착 단백질을 함유하는 용액과 도파민을 함유하는 용액을 혼합하는 단계; 및 상기 혼합된 용액을 기재 상에 도포하는 단계를 포함하는 항균 코팅의 제조방법을 제공한다.In another embodiment of the present invention, mixing a solution containing an adhesive protein to which an antimicrobial peptide is bound and a solution containing dopamine; And it provides a method for producing an antibacterial coating comprising the step of applying the mixed solution on a substrate.
본 발명에서 상기 제조방법은 상기 혼합된 용액에 산화제를 첨가하는 단계를 추가로 포함할 수 있다.In the present invention, the manufacturing method may further include the step of adding an oxidizing agent to the mixed solution.
본 발명의 또 다른 구현 양태는, 항균성 펩타이드가 결합된 접착 단백질 및 도파민을 포함하는 항균 코팅을 제공한다.Another embodiment of the present invention provides an antimicrobial coating comprising an adhesive protein to which an antimicrobial peptide is bound and dopamine.
본 발명에 따른 항균 코팅 조성물은 종래의 홍합 유래 접착제의 문제점인 장시간 접착 혹은 코팅이 필요한 단점을 개선하여 단시간에 강력한 접착력을 갖는 동시에 인체 유해한 그람 양성균, 그람 음성균, 세균, 진균 등 다양한 미생물이나 바이러스에 항균 효과를 나타낼 수 있는 코팅 조성물을 제공한다.The antimicrobial coating composition according to the present invention improves the disadvantages of conventional mussel-derived adhesives, which require long-term adhesion or coating, and has strong adhesion in a short time, and at the same time, it is resistant to various microorganisms or viruses such as gram-positive bacteria, gram-negative bacteria, bacteria, and fungi that are harmful to the human body. It provides a coating composition that can exhibit an antibacterial effect.
또한, 본 발명에 따른 항균 코팅 조성물은 기존 기술에 비해 강력한 항균력이 장기간 지속되는 특성을 가지며, 다양한 제품에 적용하기 용이한 가공성을 갖고, 특정 조건하에서 생분해되며, 코팅이나 접착시 유기용매를 사용하지 않는 친환경성이 우수하여, 의류, 화장용품, 전자기기, 의료기기 등 다양한 제품군에 대한 항균, 항바이러스, 항아토피 접착제 등의 용도로 유용하게 사용될 수 있다.In addition, the antimicrobial coating composition according to the present invention has a characteristic of long-lasting strong antibacterial activity compared to the existing technology, has processability that is easy to apply to various products, is biodegradable under certain conditions, and does not use organic solvents for coating or bonding. Because of its excellent eco-friendliness, it can be usefully used for antibacterial, antiviral, and anti-atopic adhesives for various product lines such as clothing, cosmetics, electronic devices, and medical devices.
도 1은 중성 용매에서 다양한 농도로 제조된 항균 코팅의 표면을 전자현미경 및 알파측정기로 분석한 결과를 나타낸다.
도 2는 약알칼리성 용매에서 다양한 농도 및 코팅 시간으로 제조된 항균 코팅의 두께를 알파측정기로 분석한 결과를 나타낸다.
도 3은 본 발명의 항균 코팅 조성물로 코팅된 실리콘 웨이퍼의 항균 특성을 비교한 결과이다.1 shows the results of analyzing the surface of an antimicrobial coating prepared at various concentrations in a neutral solvent with an electron microscope and an alpha analyzer.
2 shows the results of analyzing the thickness of the antimicrobial coating prepared at various concentrations and coating times in a weakly alkaline solvent with an alpha meter.
3 is a result of comparing the antibacterial properties of a silicon wafer coated with the antibacterial coating composition of the present invention.
이하, 도면을 참조하여 본 발명의 구현예에 대하여 상세하게 설명한다. 이하 설명은 본 발명의 구현예들을 용이하게 이해하기 위한 것일 뿐이며, 보호범위를 제한하기 위한 것은 아니다.Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings. The following description is only for easily understanding the embodiments of the present invention, and is not intended to limit the scope of protection.
본 발명은 생체 접착제에 기반한 항균 코팅 조성물에 관한 것으로서, 본 발명에 따른 항균 코팅 조성물은 항균성 펩타이드가 결합된 접착 단백질; 및 도파민을 포함할 수 있다.The present invention relates to an antibacterial coating composition based on a bioadhesive, wherein the antimicrobial coating composition according to the present invention comprises: an adhesive protein to which an antimicrobial peptide is bound; And dopamine.
본 발명에서 상기 접착 단백질은 습한 환경이나 건조한 환경에서 자가 접착이 가능한 접착성 단백질을 의미하며, 본질적으로 접착성을 보유하거나 혹은 화학적 개질을 통해 별도의 경화제를 첨가하지 않고 접착 혹은 코팅이 가능한 단백질을 의미한다. 시판되는 자가 접착 단백질의 예로는 미국 사우스캐롤리나주 노스 오구스타 소재 콜로디스 바이오사이언스사에 의해 시판되고 있는 홍합 유래 재조합 접착 단백질인 MAPTrix™ 혹은 서울시 구로구 소재 ㈜바이오빛이 판매하는 항균 접착 단백질이 있지만, 이에 한정되는 것은 아니다.In the present invention, the adhesive protein means an adhesive protein capable of self-adhesive in a humid environment or a dry environment, and a protein that can be adhered or coated without adding a separate curing agent is inherently adhesive or through chemical modification. it means. Examples of commercially available self-adhesive proteins include MAPTrix™, a mussel-derived recombinant adhesive protein sold by Collodis Biosciences, North Augusta, South Carolina, or an antimicrobial adhesive protein sold by Biobit Co., Ltd. in Guro-gu, Seoul. It is not limited thereto.
본 발명의 일 실시 양태에 따르면, 본 발명에서 사용 가능한 접착 단백질은 그 자체 또는 유전자 재조합적으로 기능화된 홍합(Mussel) 유래 접착 단백질, 따개비(Barnacle) 유래 접착 단백질 및 그의 조합으로 이루어진 군으로부터 선택될 수 있다.According to an embodiment of the present invention, the adhesive protein usable in the present invention may be selected from the group consisting of itself or a genetically recombinant functionalized mussel-derived adhesive protein, barnacle-derived adhesive protein, and combinations thereof. I can.
본 발명에 있어서, 상기 접착 단백질은 그 자체로 사용하거나, 서열번호 1, 2, 3 또는 4으로 기재되는 족사 단백질(foot protein)-3(FP-3), 서열번호 5, 6, 7 또는 8로 기재되는 족사 단백질-5(FP-5), 서열번호 9로 기재되는 족사 단백질-6(FP-6), 또는 서열번호 10으로 기재되는 따개비 접착 단백질의 탄소 말단이나 아민 말단 혹은 양쪽 모두에 해당하는 제1 펩타이드와 홍합 접착 단백질 FP-1(서열번호 11, 12, 13, 14, 15) 및 각 단백질의 절편으로 이루어진 군으로부터 선택되는 적어도 하나의 제2 펩타이드가 융합된 융합 단백질로서 사용될 수 있다.In the present invention, the adhesive protein is used as such, or foot protein-3 (FP-3) described in SEQ ID NO: 1, 2, 3 or 4, SEQ ID NO: 5, 6, 7 or 8 It corresponds to the carbon-terminal or amine-terminal or both of the joxa protein-5 (FP-5) of SEQ ID NO: 9, or of the barnacle adhesive protein of SEQ ID NO: 10 The first peptide and mussel adhesion protein FP-1 (SEQ ID NOs: 11, 12, 13, 14, 15) and at least one second peptide selected from the group consisting of fragments of each protein may be used as a fusion protein. .
바람직하게는, 상기 제1 펩타이드는 서열번호 5, 6, 7 또는 8의 아미노산 서열을 포함하는 FP-5 혹은 서열번호 10의 아미노산 서열을 포함하는 따개비 접착 단백질이고, 상기 제2 펩타이드는 서열번호 12 또는 14의 아미노산 서열을 포함하는 FP-1이다. 더욱 바람직하게는, 본 발명에서 이용가능한 접착 단백질은 서열번호 11, 12, 또는 14의 아미노산 서열을 포함하는 FP-1이다.Preferably, the first peptide is FP-5 comprising the amino acid sequence of SEQ ID NO: 5, 6, 7 or 8 or a barnacle adhesive protein comprising the amino acid sequence of SEQ ID NO: 10, and the second peptide is SEQ ID NO: 12 Or FP-1 comprising an amino acid sequence of 14. More preferably, the adhesive protein usable in the present invention is FP-1 comprising the amino acid sequence of SEQ ID NO: 11, 12, or 14.
본 발명에 있어서, 상기 접착 단백질은 자연에 존재하는 접착 단백질 혹은 유전자 재조합적으로 고안된 접착 단백질의 질소 혹은 탄소 말단에 항균성 펩타이드가 부가된 형태를 갖는 것이 바람직하다.In the present invention, it is preferable that the adhesive protein has a form in which an antimicrobial peptide is added to the nitrogen or carbon terminus of an adhesive protein existing in nature or an adhesive protein designed recombinantly.
본 발명에서 접착 단백질에 부가되는 항균성 펩타이드의 경우, 자연에서 유래하거나 인공적으로 합성되는 항균기능성을 나타내는 펩타이드가 사용될 수 있다. 항균 펩타이드는 미생물의 세포막을 파괴하거나 세포막을 투과하여 대사 기능을 저해하는 기작을 통해 항균 효과를 발휘한다. 본 발명에서 미생물의 세포막을 파괴하는 기작으로 항균 효과를 발휘하는 항균성 펩타이드는 모두 포함한다. 바람직하게는 접착 단백질에 부가될 항균성 펩타이드는 그램 양성균은 물론 그램 음성균에 효과가 있는 항균 펩타이드 중에서 선택될 수 있다.In the case of the antimicrobial peptide added to the adhesive protein in the present invention, a peptide exhibiting antimicrobial function derived from nature or artificially synthesized may be used. Antibacterial peptides exert an antibacterial effect through a mechanism that destroys the cell membrane of microorganisms or inhibits metabolic function by penetrating the cell membrane. In the present invention, all antimicrobial peptides exhibiting antibacterial effects as a mechanism for destroying the cell membrane of microorganisms are included. Preferably, the antimicrobial peptide to be added to the adhesive protein may be selected from antimicrobial peptides effective against gram-positive bacteria as well as gram-negative bacteria.
예를 들어, 본 발명에서 사용 가능한 바람직한 항균성 펩타이드는 KLWKKWAKKWLKLWKA(서열번호 16), FALALKALKKL(서열번호 17), ILRWPWWPWRRK(서열번호 18), AKRHHGYKRKFH(서열번호 19), KWKLFKKIGAVLKVL(서열번호 20), LVKLVAGIKKFLKWK(서열번호 21), IWSILAPLGTTLVKLVAGIGQQKRK(서열번호 22), GIGAVLKVLTTGLPALISWI(서열번호 23), SWLSKTAKKGAVLKVL(서열번호 24), KKLFKKILKYL(서열번호 25), GLKKLISWIKRAAQQG(서열번호 26), GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR(서열번호 27), LKKLAKLALAF(서열번호 28), KLLLKLLKKLLKLLKKK(서열번호 29), THRPPMWSPVWP(서열번호 30), GWLKKIGKWKIFKK(서열번호 31), ILPWKWPWWPWRR(서열번호 32), RRWWCRC(서열번호 33), KLAKLAKKLAKLAK (서열번호 34), 및 LKKLAKLALAFILRWPWWPWRRK(서열번호 35)로부터 선택될 수 있다.For example, preferred antimicrobial peptides usable in the present invention are KLWKKWAKKWLKLWKA (SEQ ID NO: 16), FALALKALKKL (SEQ ID NO: 17), ILRWPWWPWRRK (SEQ ID NO: 18), AKRHHGYKRKFH (SEQ ID NO: 19), KWKLFKKIGAVLKVL (SEQ ID NO: 20) SEQ ID NO: 21), IWSILAPLGTTLVKLVAGIGQQKRK (SEQ ID NO: 22), GIGAVLKVLTTGLPALISWI (SEQ ID NO: 23), SWLSKTAKKGAVLKVL (SEQ ID NO: 24), KKLFKKILKYL (SEQ ID NO: 25), GLKKLISWIKRAAQQQG (SEQ ID NO: 27) GLKKLISWIKRAAQQQG (SEQ ID NO: 27), GLKQLAKKTIQ, 28), KLLLKLLKKLLKLLKKK (SEQ ID NO: 29), THRPPMWSPVWP (SEQ ID NO: 30), GWLKKIGKWKIFKK (SEQ ID NO: 31), ILPWKWPWWPWRR (SEQ ID NO: 32), RRWWCRC (SEQ ID NO: 33), KLAKLAKLAKLAKLAK (SEQ ID NO: 34WPLAKLAKLAK and SEQ ID NO: Number 35).
본 발명에 있어서, 홍합 접착 단백질은 구성 아미노산 중에서 티로신 잔기를 화학적 수정을 통하여 DOPA, 또는 도파 퀴논으로 변경할 수 있다. 이렇게 수정된 도파 및 도파 퀴논은 표면에 대한 접착에 있어서 매우 중요한 역할을 할 수 있다. 유전자 재조합 홍합 접착 단백질의 화학적 수정은 이를 매개할 수 있는 버섯 유래의 티로시나아제(tyrosinase) 효소를 이용하여 수행할 수 있다. 화학적 수정을 거친 항균 홍합 접착 단백질은 금속, 플라스틱, 유리 등의 다양한 소재에 제한없이 부착될 수 있다.In the present invention, the mussel adhesion protein may change a tyrosine residue among the constituent amino acids to DOPA or dopaquinone through chemical modification. The modified waveguide and dopaquinone can play a very important role in adhesion to the surface. Chemical modification of the genetically modified mussel adhesion protein can be performed using a mushroom-derived tyrosinase enzyme that can mediate it. The antimicrobial mussel adhesive protein that has undergone chemical modification can be attached to various materials such as metal, plastic, and glass without limitation.
본 발명에서 제공하는 항균 코팅 조성물은 상기 항균 접착 단백질과 함께 도파민을 포함할 수 있다.The antibacterial coating composition provided by the present invention may include dopamine together with the antibacterial adhesive protein.
상기 도파민(dopamine)은 아래의 화학식 1에서 나타낸 바와 같이, 알킬아민(alkylamine)과 카테콜(catechol) 작용기를 포함하는 화학 구조를 가지며, 여기서 알킬아민은 리신(lysine)과 유사하며, 카테콜은 L-DOPA와 유사하다. 이러한 도파민은 유기물 또는 무기물 상에 강한 접착력을 갖는 물질이다.The dopamine has a chemical structure including an alkylamine and a catechol functional group, as shown in
본 발명에서는 항균성 펩타이드가 결합된 접착 단백질을 도파민과 함께 혼합하여 사용하는 경우, 기존의 수 시간이 소요되는 표면 코팅 시간을 수 분 이내로 단축시킬 수 있다는 것을 발견하였다. 순수 도파민의 경우 단독으로 표면 코팅을 하면 코팅 표면이 균일하지 않아 항균 효과가 표면 전체에 걸쳐 균일하지 않으나, 접착 단백질과 혼합하여 사용할 경우 표면 코팅을 비교적 균일하게 진행하여 일정 품질의 항균 효과를 발휘할 수 있다.In the present invention, it was found that when the adhesive protein to which the antimicrobial peptide is bound is mixed with dopamine, the conventional surface coating time, which takes several hours, can be shortened to within several minutes. In the case of pure dopamine, if the surface is coated alone, the antimicrobial effect is not uniform over the entire surface as the coating surface is not uniform. However, when used in combination with adhesive protein, the surface coating is relatively uniform and a certain quality of antibacterial effect can be achieved. have.
본 발명에서, 항균 코팅 조성물은 접착 단백질과 도파민을 10:1 내지 1:1의 질량비로 포함할 수 있으며, 바람직하게는 10:1 내지 5:1이며, 더욱 바람직하게는 10:1 내지 8:1의 질량비로 포함할 수 있다. 상기 도파민을 10:1 보다 낮은 비율로 사용하는 경우 접착 단백질과 표면 사이의 반응을 매개하는 비율이 감소하며, 결과적으로 부분적으로 코팅되지 않는 표면을 얻게 될 수 있어 코팅의 균일성이 감소하여 항균 효과가 일정하지 않은 문제가 있을 수 있고, 1:1보다 더 많이 사용하는 경우 도파민의 자가 중합(self-polymerization) 비율이 높아져 항균 접착 단백질과의 가교에 참여하는 도파민 비율이 감소하여 항균 접착 단백질이 표면에 코팅되는 비율 또한 감소하며 결과적으로 항균 코팅된 표면이 감소하는 문제가 발생할 수 있다.In the present invention, the antimicrobial coating composition may include the adhesive protein and dopamine in a mass ratio of 10:1 to 1:1, preferably 10:1 to 5:1, and more preferably 10:1 to 8: It can be included in a mass ratio of 1. When the dopamine is used in a ratio lower than 10:1, the ratio that mediates the reaction between the adhesive protein and the surface decreases, and as a result, a partially uncoated surface may be obtained, thereby reducing the uniformity of the coating, resulting in antibacterial effect There may be an inconsistent problem, and if it is used more than 1:1, the self-polymerization ratio of dopamine increases and the ratio of dopamine that participates in crosslinking with the antibacterial adhesive protein decreases. The rate of coating on the surface is also reduced, and as a result, the problem of decreasing the antimicrobial coated surface may occur.
본 발명에 따른 항균 코팅 조성물은 상기 접착 단백질과 도파민을 혼합하기 위한 용매를 추가로 포함할 수 있다. 본 발명에서 사용 가능한 용매는 pH 4.0 내지 10.0을 나타내는 수용성 용매는 모두 사용할 수 있으며, 특히 신속한 코팅을 위해서는 약알칼리성 용매(pH 7.0 초과 9.0 이하)를 사용하는 것이 바람직하다. 본 발명에서, 약알칼리성 용매를 제조하기 위해 바람직한 용매는 상기 pH 범위를 만족할 수 있는 물질을 자유롭게 사용할 수 있으며, 예를 들어, 초산나트륨(sodium acetate), 탄산수소나트륨(sodium bicarbonate), 아인산염(phosphate) 등의 염을 사용할 수 있고, 본 발명에서 바람직하게는 초산나트륨과 탄산수소나트륨의 혼합 용매를 사용할 수 있다.The antibacterial coating composition according to the present invention may further include a solvent for mixing the adhesive protein and dopamine. The solvent usable in the present invention may be any water-soluble solvent having a pH of 4.0 to 10.0, and in particular, for rapid coating, it is preferable to use a weakly alkaline solvent (pH greater than 7.0 and less than or equal to 9.0). In the present invention, a preferred solvent for preparing a weakly alkaline solvent may freely use a material that can satisfy the above pH range, for example, sodium acetate, sodium bicarbonate, and phosphite ( phosphate) may be used, and a mixed solvent of sodium acetate and sodium hydrogen carbonate may be preferably used in the present invention.
본 발명에서 상기 접착 단백질 및 도파민의 혼합물은 용매 내에 0.1 내지 10mg/mL의 농도로 혼합될 수 있으며, 바람직하게는 0.5 내지 2mg/mL의 농도로 혼합될 수 있다. 본 발명의 일 실시예에서는 상기 수치범위 내의 농도를 갖는 코팅 조성물이 고른 코팅 두께 분포를 갖는다는 것을 확인하였다.In the present invention, the mixture of the adhesive protein and dopamine may be mixed in a solvent at a concentration of 0.1 to 10 mg/mL, and preferably at a concentration of 0.5 to 2 mg/mL. In one embodiment of the present invention, it was confirmed that the coating composition having a concentration within the numerical range has an even coating thickness distribution.
본 발명에 따른 항균 코팅 조성물은 또한, 산화제를 추가로 포함할 수 있다. 산화제로는 철(Fe3+), 크롬(Cr6+), 망간(Mn7+) 및 요오드(I7+)로 이루어진 군으로부터 선택된 하나 이상의 금속, 과산화수소 또는 과산화이중황산나트륨(Na2S2O8)을 사용할 수 있으며, 여기에서 산화제는 상기 도파민 전체 중량에 대하여 0.01 내지 5중량부로 함유될 수 있다.The antibacterial coating composition according to the present invention may further include an oxidizing agent. The oxidizing agent is one or more metals selected from the group consisting of iron (Fe 3+ ), chromium (Cr 6+ ), manganese (Mn 7+ ) and iodine (I 7+ ), hydrogen peroxide, or sodium bisulfate peroxide (Na 2 S 2 O 8 ) may be used, wherein the oxidizing agent may be contained in an amount of 0.01 to 5 parts by weight based on the total weight of the dopamine.
본 발명에 따른 항균 코팅 조성물은 순수한 단백질로만 구성된 홍합 유래 접착제의 문제점인 장시간 접착 혹은 코팅이 필요한 단점을 개선하여 단시간에 강력한 접착력을 갖는 동시에 다양한 미생물이나 바이러스에 항균 효과를 나타낼 수 있는 코팅 조성물을 제공한다.The antimicrobial coating composition according to the present invention provides a coating composition capable of exhibiting an antibacterial effect against various microorganisms or viruses at the same time having strong adhesion in a short time by improving the disadvantage of long-term adhesion or coating, which is a problem of mussel-derived adhesives composed of pure protein do.
본 발명의 바람직한 실시 양태에 따른 항균 접착제의 분자 골격은 양수성 특징을 가져 기존 항균 코팅 제품에 첨가제로 사용할 수 있을 뿐만 아니라, 항균 접착제를 수용성 혹은 지용성 코팅제로 만들어 사용할 수 있다. 본 발명에 따른 항균 코팅 조성물은 기존 기술에 비해 강력한 항균력이 장기간 지속되는 특성을 가지며, 동시에 외부 환경이나 압력에 의해 항균 코팅제가 쉽게 손상되지 않는 내구성을 가진다. 또한, 다양한 제품에 적용하기 용이한 가공성을 갖고, 특정 조건하에서 생분해되며, 코팅이나 접착시 유기용매를 사용하지 않는 친환경성이 우수하여, 다양한 제품군에 대한 항균, 항바이러스, 항아토피 접착제 등의 용도로 유용하게 사용될 수 있다.The molecular skeleton of the antimicrobial adhesive according to a preferred embodiment of the present invention has amphiphilic properties and can be used as an additive to existing antimicrobial coating products, and the antibacterial adhesive can be used as a water-soluble or oil-soluble coating agent. The antimicrobial coating composition according to the present invention has a characteristic that a strong antibacterial activity lasts for a long time compared to the existing technology, and at the same time, it has durability that the antibacterial coating agent is not easily damaged by external environment or pressure. In addition, it has processability that is easy to apply to various products, is biodegradable under certain conditions, and has excellent eco-friendliness that does not use organic solvents during coating or bonding, and is used for antibacterial, antiviral, and anti-atopic adhesives for various product lines. Can be used usefully.
본 발명은 또한, 항균성 펩타이드가 결합된 접착 단백질 및 도파민을 용매에 용해하여 혼합 용액을 제조하는 단계; 및 상기 혼합 용액을 기재 상에 도포하는 단계를 포함하는 항균기능성 코팅의 제조방법을 제공한다.The present invention also comprises the steps of preparing a mixed solution by dissolving the antimicrobial peptide-bound adhesive protein and dopamine in a solvent; And it provides a method for producing an antimicrobial functional coating comprising the step of applying the mixed solution on a substrate.
본 발명의 항균 코팅 조성물은 공지의 코팅 방법을 이용하여 코팅할 수 있다. 예를 들어, 제1 단계로서, 접착 단백질을 pH 5.0 내지 6.0인 초산 나트륨 버퍼 용액에 10mg/mL 이상의 농도로 녹인 후 pH가 7 내지 9인 약알칼리성 버퍼로 희석하여 코팅 농도 0.1mg/mL로 만든다.The antimicrobial coating composition of the present invention may be coated using a known coating method. For example, as a first step, the adhesive protein is dissolved in a sodium acetate buffer solution having a pH of 5.0 to 6.0 at a concentration of 10 mg/mL or higher, and then diluted with a weakly alkaline buffer having a pH of 7 to 9 to obtain a coating concentration of 0.1 mg/mL. .
제2 단계로서, 도파민을 pH 5.0 내지 6.0인 초산 나트륨 버퍼에 10mg/mL의 농도로 녹인 후 약알칼리성 버퍼로 0.05mg/mL 농도로 희석한 후 접착 단백질이 용해된 약알칼리성 용액에 첨가한다.As a second step, dopamine is dissolved in a sodium acetate buffer having a pH of 5.0 to 6.0 at a concentration of 10 mg/mL, diluted to a concentration of 0.05 mg/mL with a weak alkaline buffer, and then added to a weak alkaline solution in which the adhesive protein is dissolved.
마지막 단계로, sodium periodate를 약알칼리성 버퍼에 0.01mg/mL 농도로 준비하여 접착 단백질/도파민 혼합 용액에 첨가한 후 균일하게 혼합하여 기재 상에 도포함으로써 항균기능성 코팅을 제조할 수 있다.As a final step, sodium periodate is prepared in a weak alkaline buffer at a concentration of 0.01 mg/mL, added to the adhesive protein/dopamine mixed solution, and then uniformly mixed and applied on the substrate to prepare an antibacterial functional coating.
본 발명에서 적용가능한 기재는 금속, 플라스틱, 유리, 복합소재, 생체에서 유래한 소재, 생체소재와 합성소재로 구성된 하이브리드 소재 등을 사용할 수 있다. 또한, 본 발명이 적용되는 표면은 평평한 표면, 오목한 표면, 기공성 표면, 구형 표면 등 다양한 표면에 항균 기능이 부여될 수 있다.The substrate applicable in the present invention may be a metal, plastic, glass, composite material, a material derived from a living body, a hybrid material composed of a biological material and a synthetic material, and the like. In addition, the surface to which the present invention is applied may impart antibacterial functions to various surfaces such as a flat surface, a concave surface, a porous surface, and a spherical surface.
실시예Example
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are for illustrative purposes only, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not to be construed as being limited by these examples.
제조예 1: 항균성 펩타이드 결합-유전자 재조합 홍합 접착 단백질 제조Preparation Example 1: Antimicrobial peptide binding-genetic recombinant mussel adhesive protein preparation
항균성 펩타이드가 결합된 홍합 접착 단백질의 제조를 위해, 홍합 접착 단백질 MAPTrix™의 C-말단 또는 N-말단 부위에 항균성 펩타이드 서열이 부가된 유전서열을 설계하여 코즈모 젠텍(서울, 대한민국)에 유전자 합성 제작을 의뢰하였다. 부가된 서열을 아래의 표 1에 나타내었다.For the production of mussel adhesive protein with antimicrobial peptide conjugated, a genetic sequence with an antimicrobial peptide sequence added to the C-terminal or N-terminal region of the mussel adhesive protein MAPTrix™ was designed and produced by Kozmo Gentech (Seoul, Korea). I requested. The added sequence is shown in Table 1 below.
항균성 펩타이드가 결합된 홍합 접착 단백질을 0.1M 초산나트륨 버퍼에 1 mg/㎖의 농도로 녹인 후, 산소 가스를 주입하여 30분 동안 계면활성 접착 단백질 용액 내 산소를 포화시켰다. 이 후, 항균 접착 단백질 1mg 당 5㎍의 농도로 티로시나아제를 첨가한 후, 산소를 주입하면서 1시간 동안 교반하였다. 1시간 후, 5% 아세트산을 첨가하여 화학적 수정 반응을 종료하였다. 반응 종료된 접착 단백질 용액은 동결건조를 진행하여 분말로 수득하였다. 상기 과정을 통하여 티로신 잔기가 DOPA로 수정된 홍합 접착 단백질을 수득하였다.The mussel adhesive protein bound with the antimicrobial peptide was dissolved in 0.1M sodium acetate buffer at a concentration of 1 mg/ml, and oxygen gas was injected to saturate oxygen in the surface-active adhesive protein solution for 30 minutes. Thereafter, tyrosinase was added at a concentration of 5 μg per 1 mg of antimicrobial adhesive protein, followed by stirring for 1 hour while injecting oxygen. After 1 hour, 5% acetic acid was added to terminate the chemical modification reaction. The adhesive protein solution after the reaction was lyophilized to obtain a powder. Through the above process, a mussel adhesive protein in which the tyrosine residue was modified with DOPA was obtained.
제조예 2: 항균 코팅 조성물 및 항균기능성 코팅의 제조Preparation Example 2: Preparation of antibacterial coating composition and antibacterial functional coating
제조예 1에서 수득한 접착 단백질 1mg 및 도파민 0.1mg을 각각 용매에 녹이고, 두 용액을 혼합하여 항균 코팅 조성물 용액을 제조하였다.1 mg of the adhesive protein obtained in Preparation Example 1 and 0.1 mg of dopamine were each dissolved in a solvent, and the two solutions were mixed to prepare an antibacterial coating composition solution.
상기 용매는 pH 7의 탈염수와 pH 8의 초산나트륨을 아래의 실시예에 맞도록 사용하였다.As the solvent, demineralized water of
준비된 시료에 산화제로서 과산화이중황산나트륨(Na2S2O8)을 도파민에 대하여 1질량부씩 첨가하여 항균 코팅 조성물을 제조하였다.Sodium peroxide bisulfate (Na 2 S 2 O 8 ) as an oxidizing agent was added to the prepared sample by 1 part by mass based on dopamine to prepare an antibacterial coating composition.
폴리스티렌 마이크로웰 플레이트 표면에 실리콘 웨이퍼 시편을 놓고 그 시편에 제조된 코팅 조성물을 피펫을 이용하여 1mL씩 도포하여 표면 코팅을 진행하였다.A silicon wafer specimen was placed on the surface of a polystyrene microwell plate, and 1 mL of the prepared coating composition was applied to the specimen using a pipette to perform surface coating.
코팅이 끝난 후 코팅 용액을 제거하고 증류수로 표면을 세척한 후 클린 벤치에서 표면을 건조시켜 항균 접착 단백질이 코팅된 실리콘 웨이퍼를 제조하였다. After the coating was completed, the coating solution was removed, the surface was washed with distilled water, and the surface was dried on a clean bench to prepare a silicon wafer coated with an antibacterial adhesive protein.
실시예 1. 코팅 표면의 분석Example 1. Analysis of the coating surface
1-1: 중성 용매에서의 코팅 표면 분석1-1: Analysis of the coating surface in a neutral solvent
중성(pH 7) 용매에 항균 홍합 접착 단백질/도파민의 중량비가 10/1인 혼합 용액을 코팅 농도 0.1mg/mL, 0.5mg/mL, 1.0mg/mL 및 2.0mg/mL로 하여 30분간 실리콘 웨이퍼를 코팅한 결과를 전자현미경으로 표면을 관찰하고, 알파 스텝 측정기(Surface Profiler, DektakXT, 미국 Bruker사)로 코팅 두께를 측정한 결과를 도 1에 나타내었다.Silicon wafer for 30 minutes in a neutral (pH 7) solvent with a mixed solution of antimicrobial mussel adhesive protein/dopamine having a weight ratio of 10/1 at coating concentrations of 0.1 mg/mL, 0.5 mg/mL, 1.0 mg/mL and 2.0 mg/mL The result of coating the surface was observed with an electron microscope, and the result of measuring the coating thickness with an alpha step measuring device (Surface Profiler, DektakXT, USA Bruker) is shown in FIG. 1.
도 1에서 확인 가능한 바와 같이, 중성 용매 하에서, 접착 단백질/도파민의 혼합 용액의 농도가 2.0mg/mL인 시료는 비교적 균일하게 표면이 코팅되었으나(도 1(d)), 그 이하의 농도에서는 두께가 불균일한 코팅이 형성되었음을 알 수 있다(도 1(a) 내지 (c)).As can be seen in FIG. 1, in a neutral solvent, the sample having a concentration of 2.0 mg/mL of an adhesive protein/dopamine mixture was coated with a relatively uniform surface (FIG. 1(d)), but at a concentration below that It can be seen that a non-uniform coating was formed (FIGS. 1(a) to (c)).
1-2: 약알칼리성 용매에서의 코팅 표면 분석1-2: Analysis of coating surface in weakly alkaline solvent
약알칼리성(pH 8) 용매에 항균 홍합 접착 단백질/도파민의 중량비가 10/1인 혼합 용액을 코팅 농도 0.5mg/mL 및 1.0mg/mL으로 하고 각각 30분 및 1시간 동안 실리콘 웨이퍼를 코팅하여 항균기능성 코팅을 얻었다. 얻어진 코팅을 알파 측정기로 코팅 두께를 측정한 결과를 도 2에 나타내었다.Antimicrobial by coating a silicone wafer with a coating concentration of 0.5mg/mL and 1.0mg/mL in a weak alkaline (pH 8) solvent with a weight ratio of antimicrobial mussel adhesive protein/dopamine of 10/1 and coating a silicon wafer for 30 minutes and 1 hour, respectively. A functional coating was obtained. The result of measuring the coating thickness of the obtained coating with an alpha meter is shown in FIG. 2.
도 2에서, 약알칼리성 용매 하에서는 낮은 농도(0.5mg/mL)에서도 비교적 표면 코팅이 균일하게 진행되었음을 알 수 있다.In FIG. 2, it can be seen that the surface coating was relatively uniformly performed even at a low concentration (0.5 mg/mL) under a weakly alkaline solvent.
또한, 코팅 두께를 증가하기 위해서 코팅 시간을 1시간으로 길게 한 경우에도 마찬가지로 표면 전체에 걸쳐 균일한 두께의 코팅층을 만들 수 있다는 것이 확인되었다. 코팅 두께는 코팅 용액의 농도에 비례적으로 증가하였다.In addition, it was confirmed that even when the coating time was lengthened to 1 hour in order to increase the coating thickness, a coating layer having a uniform thickness over the entire surface could be formed. The coating thickness increased proportionally with the concentration of the coating solution.
실시예 2: 항균기능성 코팅의 항균 효과 측정Example 2: Measurement of antibacterial effect of antibacterial functional coating
실시예 1-2에서 제조된 0.5mg/mL의 농도의 항균기능성 코팅에 대하여 항균 효과를 시험하였다.The antibacterial effect was tested for the antimicrobial functional coating of 0.5mg/mL prepared in Example 1-2.
미리 배양된 포도상구균(S. Aureus)을 104CFU/ml이 되도록 PBS로 희석한 후, 상기 항균기능성 코팅이 코팅된 실리콘 웨이퍼와 코팅되지 않은 실리콘 웨이퍼 상에 포도상구균을 각각 접종하여 항균 효과를 비교 측정하였다.After diluting the previously cultured Staphylococcus aureus ( S. Aureus ) with PBS to 10 4 CFU/ml, the antimicrobial effect was obtained by inoculating Staphylococcus aureus on the coated silicon wafer and the non-coated silicon wafer respectively. Comparative measurements were made.
도 3에 나타낸 바와 같이, 본 발명의 항균 코팅 조성물로 코팅된 웨이퍼의 항균력 측정 결과 시간에 상관없이 단단한 표면임에도 불구하고 약 90% 이상의 항균 효과를 확인하였다.As shown in FIG. 3, as a result of measuring the antibacterial activity of the wafer coated with the antibacterial coating composition of the present invention, it was confirmed that the antibacterial effect was about 90% or more despite the hard surface regardless of time.
<110> Biovit Co., Ltd. <120> Antimicrobial Adhesive Composition and Method For Preparing Same <130> JPN18002 <160> 35 <170> KoPatentIn 3.0 <210> 1 <211> 52 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis) <400> 1 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys 20 25 30 Gly Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 Glu Phe Glu Phe 50 <210> 2 <211> 46 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus galloprovincialis : mgfp-3A) <400> 2 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Arg Arg Tyr Gly Gly Tyr Lys Gly Trp 20 25 30 Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 <210> 3 <211> 50 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis: mefp-3F) <400> 3 Ala Asp Tyr Tyr Gly Pro Asn Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Asn Gly Tyr Gly Gly Gly Arg Arg Tyr Gly 20 25 30 Gly Tyr Lys Gly Trp Asn Asn Gly Trp Asn Arg Gly Arg Arg Gly Lys 35 40 45 Tyr Trp 50 <210> 4 <211> 44 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus californianus) <400> 4 Gly Ala Tyr Lys Gly Pro Asn Tyr Asn Tyr Pro Trp Arg Tyr Gly Gly 1 5 10 15 Lys Tyr Asn Gly Tyr Lys Gly Tyr Pro Arg Gly Tyr Gly Trp Asn Lys 20 25 30 Gly Trp Asn Lys Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 <210> 5 <211> 75 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 5 (FP-5, Mytilus edulis) <400> 5 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Ser Ser 65 70 75 <210> 6 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus edulis) <400> 6 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 7 <211> 71 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus coruscus) <400> 7 Tyr Asp Asp Tyr Ser Asp Gly Tyr Tyr Pro Gly Ser Ala Tyr Asn Tyr 1 5 10 15 Pro Ser Gly Ser His Trp His Gly His Gly Tyr Lys Gly Lys Tyr Tyr 20 25 30 Gly Lys Gly Lys Lys Tyr Tyr Tyr Lys Phe Lys Arg Thr Gly Lys Tyr 35 40 45 Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys 50 55 60 His Tyr Gly Gly Ser Ser Ser 65 70 <210> 8 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus galloprovincialis) <400> 8 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 9 <211> 99 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 6 (FP-6, Mytilus edulis) <400> 9 Gly Gly Gly Asn Tyr Arg Gly Tyr Cys Ser Asn Lys Gly Cys Arg Ser 1 5 10 15 Gly Tyr Ile Phe Tyr Asp Asn Arg Gly Phe Cys Lys Tyr Gly Ser Ser 20 25 30 Ser Tyr Lys Tyr Asp Cys Gly Asn Tyr Ala Gly Cys Cys Leu Pro Arg 35 40 45 Asn Pro Tyr Gly Arg Val Lys Tyr Tyr Cys Thr Lys Lys Tyr Ser Cys 50 55 60 Pro Asp Asp Phe Tyr Tyr Tyr Asn Asn Lys Gly Tyr Tyr Tyr Tyr Asn 65 70 75 80 Asp Lys Asp Tyr Phe Asn Cys Gly Ser Tyr Asn Gly Cys Cys Leu Arg 85 90 95 Ser Gly Tyr <210> 10 <211> 56 <212> PRT <213> Artificial Sequence <220> <223> Semibalanus balanoides <400> 10 Met Arg Val Ile Leu Phe Ala Met Leu Ile Gly Gly Ser Leu Ala Cys 1 5 10 15 Gln Asn Arg Leu Glu Thr Leu Val Gln Glu Ala Thr Gly Asn Ala Gly 20 25 30 Asp Leu Ser Thr Asn Val His Glu Glu Cys Asn Ser Gln Val Gly Thr 35 40 45 Phe Asn Ala Val His Ala Pro Gln 50 55 <210> 11 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Decapeptide (FP-1, Mytilus edulis) <400> 11 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 1 5 10 <210> 12 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> 2 time repeated decapeptide (FP-1, Mytilus edulis) <400> 12 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys 20 <210> 13 <211> 30 <212> PRT <213> Artificial Sequence <220> <223> 3 times repeated decapeptide (FP-1, Mytilus edulis) <400> 13 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 20 25 30 <210> 14 <211> 40 <212> PRT <213> Artificial Sequence <220> <223> 4 times repeated decapeptide (FP-1, Mytilus edulis) <400> 14 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys 35 40 <210> 15 <211> 60 <212> PRT <213> Artificial Sequence <220> <223> 6 times repeated decapeptide (FP-1, Mytilus edulis) <400> 15 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 50 55 60 <210> 16 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLWKKWAKKWLKLWKA) <400> 16 Lys Leu Trp Lys Lys Trp Ala Lys Lys Trp Leu Lys Leu Trp Lys Ala 1 5 10 15 <210> 17 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (FALALKALKKL) <400> 17 Phe Ala Leu Ala Leu Lys Ala Leu Lys Lys Leu 1 5 10 <210> 18 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (ILRWPWWPWRRK) <400> 18 Ile Leu Arg Trp Pro Trp Trp Pro Trp Arg Arg Lys 1 5 10 <210> 19 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (AKRHHGYKRKFH) <400> 19 Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His 1 5 10 <210> 20 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KWKLFKKIGAVLKVL) <400> 20 Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 21 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LVKLVAGIKKFLKWK) <400> 21 Leu Val Lys Leu Val Ala Gly Ile Lys Lys Phe Leu Lys Trp Lys 1 5 10 15 <210> 22 <211> 25 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (IWSILAPLGTTLVKLVAGIGQQKRK) <400> 22 Ile Trp Ser Ile Leu Ala Pro Leu Gly Thr Thr Leu Val Lys Leu Val 1 5 10 15 Ala Gly Ile Gly Gln Gln Lys Arg Lys 20 25 <210> 23 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GIGAVLKVLTTGLPALISWI) <400> 23 Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 1 5 10 15 Ile Ser Trp Ile 20 <210> 24 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (SWLSKTAKKGAVLKVL) <400> 24 Ser Trp Leu Ser Lys Thr Ala Lys Lys Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 25 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KKLFKKILKYL) <400> 25 Lys Lys Leu Phe Lys Lys Ile Leu Lys Tyr Leu 1 5 10 <210> 26 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GLKKLISWIKRAAQQG) <400> 26 Gly Leu Lys Lys Leu Ile Ser Trp Ile Lys Arg Ala Ala Gln Gln Gly 1 5 10 15 <210> 27 <211> 39 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR) <400> 27 Gly Trp Leu Lys Lys Ile Gly Lys Lys Ile Glu Arg Val Gly Gln His 1 5 10 15 Thr Arg Asp Ala Thr Ile Gln Gly Leu Gly Ile Ala Gln Gln Ala Ala 20 25 30 Asn Val Ala Ala Thr Ala Arg 35 <210> 28 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LKKLAKLALAF) <400> 28 Leu Lys Lys Leu Ala Lys Leu Ala Leu Ala Phe 1 5 10 <210> 29 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLLLKLLKKLLKLLKKK) <400> 29 Lys Leu Leu Leu Lys Leu Leu Lys Lys Leu Leu Lys Leu Leu Lys Lys 1 5 10 15 Lys <210> 30 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (THRPPMWSPVWP) <400> 30 Thr His Arg Pro Pro Met Trp Ser Pro Val Trp Pro 1 5 10 <210> 31 <211> 14 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GWLKKIGKWKIFKK) <400> 31 Gly Trp Leu Lys Lys Ile Gly Lys Trp Lys Ile Phe Lys Lys 1 5 10 <210> 32 <211> 13 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (ILPWKWPWWPWRR) <400> 32 Ile Leu Pro Trp Lys Trp Pro Trp Trp Pro Trp Arg Arg 1 5 10 <210> 33 <211> 7 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (RRWWCRC) <400> 33 Arg Arg Trp Trp Cys Arg Cys 1 5 <210> 34 <211> 14 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLAKLAKKLAKLAK) <400> 34 Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 1 5 10 <210> 35 <211> 23 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LKKLAKLALAFILRWPWWPWRRK) <400> 35 Leu Lys Lys Leu Ala Lys Leu Ala Leu Ala Phe Ile Leu Arg Trp Pro 1 5 10 15 Trp Trp Pro Trp Arg Arg Lys 20 <110> Biovit Co., Ltd. <120> Antimicrobial Adhesive Composition and Method For Preparing Same <130> JPN18002 <160> 35 <170> KoPatentIn 3.0 <210> 1 <211> 52 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis) <400> 1 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Gly Ser Arg Arg Tyr Gly Gly Tyr Lys 20 25 30 Gly Trp Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 Glu Phe Glu Phe 50 <210> 2 <211> 46 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus galloprovincialis: mgfp-3A) <400> 2 Ala Asp Tyr Tyr Gly Pro Lys Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Gly Arg Arg Tyr Gly Gly Tyr Lys Gly Trp 20 25 30 Asn Asn Gly Trp Lys Arg Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 45 <210> 3 <211> 50 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus edulis: mefp-3F) <400> 3 Ala Asp Tyr Tyr Gly Pro Asn Tyr Gly Pro Pro Arg Arg Tyr Gly Gly 1 5 10 15 Gly Asn Tyr Asn Arg Tyr Asn Gly Tyr Gly Gly Gly Arg Arg Tyr Gly 20 25 30 Gly Tyr Lys Gly Trp Asn Asn Gly Trp Asn Arg Gly Arg Arg Gly Lys 35 40 45 Tyr Trp 50 <210> 4 <211> 44 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 3 (FP-3, Mytilus californianus) <400> 4 Gly Ala Tyr Lys Gly Pro Asn Tyr Asn Tyr Pro Trp Arg Tyr Gly Gly 1 5 10 15 Lys Tyr Asn Gly Tyr Lys Gly Tyr Pro Arg Gly Tyr Gly Trp Asn Lys 20 25 30 Gly Trp Asn Lys Gly Arg Trp Gly Arg Lys Tyr Tyr 35 40 <210> 5 <211> 75 <212> PRT <213> Artificial Sequence <220> <223> Foot protein type 5 (FP-5, Mytilus edulis) <400> 5 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Ala Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Ser Ser 65 70 75 <210> 6 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus edulis) <400> 6 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 7 <211> 71 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus coruscus) <400> 7 Tyr Asp Asp Tyr Ser Asp Gly Tyr Tyr Pro Gly Ser Ala Tyr Asn Tyr 1 5 10 15 Pro Ser Gly Ser His Trp His Gly His Gly Tyr Lys Gly Lys Tyr Tyr 20 25 30 Gly Lys Gly Lys Lys Tyr Tyr Tyr Lys Phe Lys Arg Thr Gly Lys Tyr 35 40 45 Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg Lys Gly Tyr Lys Lys 50 55 60 His Tyr Gly Gly Ser Ser Ser 65 70 <210> 8 <211> 76 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 5 (FP-5, Mytilus galloprovincialis) <400> 8 Ser Ser Glu Glu Tyr Lys Gly Gly Tyr Tyr Pro Gly Asn Thr Tyr His 1 5 10 15 Tyr His Ser Gly Gly Ser Tyr His Gly Ser Gly Tyr His Gly Gly Tyr 20 25 30 Lys Gly Lys Tyr Tyr Gly Lys Ala Lys Lys Tyr Tyr Tyr Lys Tyr Lys 35 40 45 Asn Ser Gly Lys Tyr Lys Tyr Leu Lys Lys Ala Arg Lys Tyr His Arg 50 55 60 Lys Gly Tyr Lys Lys Tyr Tyr Gly Gly Gly Ser Ser 65 70 75 <210> 9 <211> 99 <212> PRT <213> Artificial Sequence <220> <223> Foot protein 6 (FP-6, Mytilus edulis) <400> 9 Gly Gly Gly Asn Tyr Arg Gly Tyr Cys Ser Asn Lys Gly Cys Arg Ser 1 5 10 15 Gly Tyr Ile Phe Tyr Asp Asn Arg Gly Phe Cys Lys Tyr Gly Ser Ser 20 25 30 Ser Tyr Lys Tyr Asp Cys Gly Asn Tyr Ala Gly Cys Cys Leu Pro Arg 35 40 45 Asn Pro Tyr Gly Arg Val Lys Tyr Tyr Cys Thr Lys Lys Tyr Ser Cys 50 55 60 Pro Asp Asp Phe Tyr Tyr Tyr Asn Asn Lys Gly Tyr Tyr Tyr Tyr Asn 65 70 75 80 Asp Lys Asp Tyr Phe Asn Cys Gly Ser Tyr Asn Gly Cys Cys Leu Arg 85 90 95 Ser Gly Tyr <210> 10 <211> 56 <212> PRT <213> Artificial Sequence <220> <223> Semibalanus balanoides <400> 10 Met Arg Val Ile Leu Phe Ala Met Leu Ile Gly Gly Ser Leu Ala Cys 1 5 10 15 Gln Asn Arg Leu Glu Thr Leu Val Gln Glu Ala Thr Gly Asn Ala Gly 20 25 30 Asp Leu Ser Thr Asn Val His Glu Glu Cys Asn Ser Gln Val Gly Thr 35 40 45 Phe Asn Ala Val His Ala Pro Gln 50 55 <210> 11 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Decapeptide (FP-1, Mytilus edulis) <400> 11 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 1 5 10 <210> 12 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> 2 time repeated decapeptide (FP-1, Mytilus edulis) <400> 12 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys 20 <210> 13 <211> 30 <212> PRT <213> Artificial Sequence <220> <223> 3 times repeated decapeptide (FP-1, Mytilus edulis) <400> 13 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 20 25 30 <210> 14 <211> 40 <212> PRT <213> Artificial Sequence <220> <223> 4 times repeated decapeptide (FP-1, Mytilus edulis) <400> 14 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys 35 40 <210> 15 <211> 60 <212> PRT <213> Artificial Sequence <220> <223> 6 times repeated decapeptide (FP-1, Mytilus edulis) <400> 15 Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro 1 5 10 15 Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys 20 25 30 Pro Ser Tyr Pro Pro Thr Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr 35 40 45 Tyr Lys Ala Lys Pro Ser Tyr Pro Pro Thr Tyr Lys 50 55 60 <210> 16 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLWKKWAKKWLKLWKA) <400> 16 Lys Leu Trp Lys Lys Trp Ala Lys Lys Trp Leu Lys Leu Trp Lys Ala 1 5 10 15 <210> 17 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (FALALKALKKL) <400> 17 Phe Ala Leu Ala Leu Lys Ala Leu Lys Lys Leu 1 5 10 <210> 18 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (ILRWPWWPWRRK) <400> 18 Ile Leu Arg Trp Pro Trp Trp Pro Trp Arg Arg Lys 1 5 10 <210> 19 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (AKRHHGYKRKFH) <400> 19 Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His 1 5 10 <210> 20 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KWKLFKKIGAVLKVL) <400> 20 Lys Trp Lys Leu Phe Lys Lys Ile Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 21 <211> 15 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LVKLVAGIKKFLKWK) <400> 21 Leu Val Lys Leu Val Ala Gly Ile Lys Lys Phe Leu Lys Trp Lys 1 5 10 15 <210> 22 <211> 25 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (IWSILAPLGTTLVKLVAGIGQQKRK) <400> 22 Ile Trp Ser Ile Leu Ala Pro Leu Gly Thr Thr Leu Val Lys Leu Val 1 5 10 15 Ala Gly Ile Gly Gln Gln Lys Arg Lys 20 25 <210> 23 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GIGAVLKVLTTGLPALISWI) <400> 23 Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 1 5 10 15 Ile Ser Trp Ile 20 <210> 24 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (SWLSKTAKKGAVLKVL) <400> 24 Ser Trp Leu Ser Lys Thr Ala Lys Lys Gly Ala Val Leu Lys Val Leu 1 5 10 15 <210> 25 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KKLFKKILKYL) <400> 25 Lys Lys Leu Phe Lys Lys Ile Leu Lys Tyr Leu 1 5 10 <210> 26 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GLKKLISWIKRAAQQG) <400> 26 Gly Leu Lys Lys Leu Ile Ser Trp Ile Lys Arg Ala Ala Gln Gln Gly 1 5 10 15 <210> 27 <211> 39 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR) <400> 27 Gly Trp Leu Lys Lys Ile Gly Lys Lys Ile Glu Arg Val Gly Gln His 1 5 10 15 Thr Arg Asp Ala Thr Ile Gln Gly Leu Gly Ile Ala Gln Gln Ala Ala 20 25 30 Asn Val Ala Ala Thr Ala Arg 35 <210> 28 <211> 11 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LKKLAKLALAF) <400> 28 Leu Lys Lys Leu Ala Lys Leu Ala Leu Ala Phe 1 5 10 <210> 29 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLLLKLLKKLLKLLKKK) <400> 29 Lys Leu Leu Leu Lys Leu Leu Lys Lys Leu Leu Lys Leu Leu Lys Lys 1 5 10 15 Lys <210> 30 <211> 12 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (THRPPMWSPVWP) <400> 30 Thr His Arg Pro Pro Met Trp Ser Pro Val Trp Pro 1 5 10 <210> 31 <211> 14 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (GWLKKIGKWKIFKK) <400> 31 Gly Trp Leu Lys Lys Ile Gly Lys Trp Lys Ile Phe Lys Lys 1 5 10 <210> 32 <211> 13 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (ILPWKWPWWPWRR) <400> 32 Ile Leu Pro Trp Lys Trp Pro Trp Trp Pro Trp Arg Arg 1 5 10 <210> 33 <211> 7 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (RRWWCRC) <400> 33 Arg Arg Trp Trp Cys Arg Cys 1 5 <210> 34 <211> 14 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (KLAKLAKKLAKLAK) <400> 34 Lys Leu Ala Lys Leu Ala Lys Lys Leu Ala Lys Leu Ala Lys 1 5 10 <210> 35 <211> 23 <212> PRT <213> Artificial Sequence <220> <223> Anti-microbacterial peptide (LKKLAKLALAFILRWPWWPWRRK) <400> 35 Leu Lys Lys Leu Ala Lys Leu Ala Leu Ala Phe Ile Leu Arg Trp Pro 1 5 10 15 Trp Trp Pro Trp Arg Arg Lys 20
Claims (11)
상기 접착 단백질이 홍합(Mussel) 유래 접착 단백질, 따개비(Barnacle) 유래 접착 단백질 및 이들의 조합으로 구성된 군에서 선택되는, 항균 코팅 조성물.Adhesion protein to which antimicrobial peptides are bound; And as an antibacterial coating composition comprising dopamine in a weight ratio of 10:1 to 8:1,
The adhesive protein is selected from the group consisting of mussel (Mussel)-derived adhesive protein, barnacle-derived adhesive protein, and combinations thereof.
상기 접착 단백질이 티로신 잔기가 도파(DOPA) 또는 도파 퀴논으로 수정된 것을 특징으로 하는, 항균 코팅 조성물.The method of claim 1,
The adhesion protein is characterized in that the tyrosine residue is modified with dopa (DOPA) or dopa quinone, antibacterial coating composition.
pH 7.0 초과 9.0 이하의 용매를 추가로 포함하는 항균 코팅 조성물.The method of claim 1,
An antimicrobial coating composition further comprising a solvent of more than pH 7.0 and less than or equal to 9.0.
상기 용매가 초산나트륨(sodium acetate), 탄산수소나트륨(sodium bicarbonate), 아인산염(phosphate) 및 이들의 조합으로부터 선택되는 것을 특징으로 하는, 항균 코팅 조성물.The method of claim 5,
The antibacterial coating composition, characterized in that the solvent is selected from sodium acetate, sodium bicarbonate, phosphate, and combinations thereof.
철(Fe3+), 크롬(Cr6+), 망간(Mn7+) 및 요오드(I7+)로 이루어진 군으로부터 선택된 하나 이상의 금속, 과산화수소 및 과산화이중황산나트륨(Na2S2O8)으로 구성된 군에서 선택되는 산화제를 추가로 포함하는 항균 코팅 조성물.The method of claim 1,
At least one metal selected from the group consisting of iron (Fe 3+ ), chromium (Cr 6+ ), manganese (Mn 7+ ) and iodine (I 7+ ), hydrogen peroxide and sodium peroxide disulfate (Na 2 S 2 O 8 ) An antibacterial coating composition further comprising an oxidizing agent selected from the group consisting of.
상기 혼합 용액을 기재 상에 도포하는 단계
를 포함하는 항균 코팅의 제조방법으로서,
상기 접착 단백질이 홍합(Mussel) 유래 접착 단백질, 따개비(Barnacle) 유래 접착 단백질 및 이들의 조합으로 구성된 군에서 선택되는, 항균 코팅의 제조방법.Preparing a mixed solution by dissolving the antimicrobial peptide-bound adhesive protein and dopamine in a solvent at a weight ratio of 10:1 to 8:1; And
Applying the mixed solution on a substrate
As a method for producing an antibacterial coating comprising a,
The adhesive protein is selected from the group consisting of mussel-derived adhesive protein, barnacle-derived adhesive protein, and combinations thereof.
상기 혼합 용액에 철(Fe3+), 크롬(Cr6+), 망간(Mn7+) 및 요오드(I7+)로 이루어진 군으로부터 선택된 하나 이상의 금속, 과산화수소 및 과산화이중황산나트륨(Na2S2O8)으로 구성된 군에서 선택되는 산화제를 첨가하는 단계를 추가로 포함하는 항균 코팅의 제조방법.The method of claim 8,
At least one metal selected from the group consisting of iron (Fe 3+ ), chromium (Cr 6+ ), manganese (Mn 7+ ), and iodine (I 7+ ), hydrogen peroxide, and sodium peroxide bisulfate (Na 2 S 2 ) in the mixed solution O 8 ) Method for producing an antibacterial coating further comprising the step of adding an oxidizing agent selected from the group consisting of.
상기 용매가 pH 7.0 초과 9.0 이하의 범위를 갖는 것을 특징으로 하는, 항균 코팅의 제조방법.The method of claim 8,
The method for producing an antimicrobial coating, characterized in that the solvent has a pH range of more than 7.0 and 9.0 or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180143688A KR102195156B1 (en) | 2018-11-20 | 2018-11-20 | Antimicrobial Adhesive Composition and Method For Preparing Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180143688A KR102195156B1 (en) | 2018-11-20 | 2018-11-20 | Antimicrobial Adhesive Composition and Method For Preparing Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200058949A KR20200058949A (en) | 2020-05-28 |
KR102195156B1 true KR102195156B1 (en) | 2020-12-28 |
Family
ID=70920405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180143688A KR102195156B1 (en) | 2018-11-20 | 2018-11-20 | Antimicrobial Adhesive Composition and Method For Preparing Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102195156B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112868668A (en) * | 2021-03-19 | 2021-06-01 | 常州英诺升康生物医药科技有限公司 | Fe3O4-DA-AMP nano composite antibacterial material and preparation method and application thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022145518A1 (en) * | 2020-12-29 | 2022-07-07 | 주식회사 바이오빛 | Hard coating composition comprising antibacterial protein and method for preparing same |
KR20220094405A (en) * | 2020-12-29 | 2022-07-06 | 주식회사 바이오빛 | Composition for Hard Coating Comprising Antimicrobial Protein and Method of Preparing the Same |
CN115068664A (en) * | 2021-03-12 | 2022-09-20 | 浦项工科大学校产学协力团 | Bioadhesive compositions comprising mussel adhesive proteins and methods of making the same |
CN114796625B (en) * | 2022-03-23 | 2023-11-24 | 杨青青 | Antibacterial antioxidant bioabsorbable material and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101340022B1 (en) * | 2011-09-20 | 2013-12-10 | 한국과학기술원 | Method for coating polydopamine |
KR101652263B1 (en) * | 2014-06-13 | 2016-08-30 | (주)콜로디스 바이오사이언스 | Adhesive Protein Comprising Antimicrobial Peptide and Antimicrobial Coating Composition Comprising the Same |
KR102283811B1 (en) * | 2016-09-28 | 2021-07-30 | 코오롱인더스트리 주식회사 | Quinone-type curing composition and additive composition using the same |
KR102441827B1 (en) * | 2017-04-20 | 2022-09-08 | 주식회사 아모그린텍 | A catecholamine coating composition and coating method for the same |
-
2018
- 2018-11-20 KR KR1020180143688A patent/KR102195156B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112868668A (en) * | 2021-03-19 | 2021-06-01 | 常州英诺升康生物医药科技有限公司 | Fe3O4-DA-AMP nano composite antibacterial material and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20200058949A (en) | 2020-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102195156B1 (en) | Antimicrobial Adhesive Composition and Method For Preparing Same | |
Han et al. | Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing | |
Wei et al. | Bridging adhesion of mussel-inspired peptides: role of charge, chain length, and surface type | |
Yang et al. | A biocompatible and functional adhesive amine-rich coating based on dopamine polymerization | |
Yeo et al. | The effects of PVA/chitosan/fibroin (PCF)-blended spongy sheets on wound Heailng in rats | |
Podsiadlo et al. | Fusion of seashell nacre and marine bioadhesive analogs: high‐strength nanocomposite by layer‐by‐layer assembly of clay and L‐3, 4‐dihydroxyphenylalanine polymer | |
Raphel et al. | Photoreactive elastin-like proteins for use as versatile bioactive materials and surface coatings | |
Stape et al. | Dentin bond optimization using the dimethyl sulfoxide-wet bonding strategy: A 2-year in vitro study | |
EP2164864B1 (en) | Synthetic repetitive proteins, the production and use thereof | |
Sogawa et al. | 3, 4-Dihydroxyphenylalanine (DOPA)-containing silk fibroin: its enzymatic synthesis and adhesion properties | |
KR101950009B1 (en) | Biocompatible Composition for Rapid Synthesis of Antimicrobial Cosmetic Puff and Method for Preparation thereof | |
KR20170071792A (en) | Functional coating composition and fabric using the same | |
MXPA06011039A (en) | Mussel bioadhesive. | |
US7186690B2 (en) | Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions | |
CN1919364A (en) | Polyurethane material with anticoagulant and thrombus dissolving functions and preparation method and application thereof | |
CN109642207A (en) | Hydrogel precursor preparation and application thereof | |
Lanza et al. | Innovative surface treatments for improved ceramic bonding: Lithium disilicate glass ceramic | |
CN106750450A (en) | Preparation method containing epoxy phosphoryl choline polymer and dopamine crosslinking adhesion bionic coating | |
Jiang et al. | Preparation and antifouling properties of 2-(meth-acryloyloxy) ethyl cholinephosphate based polymers modified surface with different molecular architectures by ATRP | |
CN108129687B (en) | A kind of surface is the preparation method of the imitating cell outer-layer membrane structure coating of Phosphorylcholine | |
US20140315789A1 (en) | Antimicrobial peptides and uses thereof | |
CN109824885B (en) | Cysteine modified mussel bionic tissue adhesive and preparation method thereof | |
Yao et al. | Dopamine enhances the mechanical and biological properties of enzyme-induced mineralized hydrogels | |
KR101898856B1 (en) | Crosslinked materials prepared by using tyrosinase from actinobacteria, method for preparation thereof, and application thereof | |
KR20230091672A (en) | Antimicrobial Nanoparticle Composition and Method For Preparing Same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |